Newsfiscal.ai
Liontrust Investment Partners Discloses 4.9% Stake in MaxCyte, Inc.
· Published
Article summary
Liontrust Investment Partners LLP has filed a Schedule 13D disclosing a 4.92% ownership stake in MaxCyte, Inc., consisting of 5,081,403 shares.
An excerpt from the original article.Analyzed by WAPE AI.
Preparing English content…


Comments —
Loading comments…